183 related articles for article (PubMed ID: 3342099)
41. In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters.
Baer HP; Serignese V; Moorji A; Van Belle H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):365-9. PubMed ID: 1852220
[TBL] [Abstract][Full Text] [Related]
42. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides.
Dagnino L; Paterson AR
Cancer Res; 1990 Oct; 50(20):6549-53. PubMed ID: 1698538
[TBL] [Abstract][Full Text] [Related]
43. [3H]dipyridamole binding to nucleoside transporters from guinea-pig and rat lung.
Shi MM; Young JD
Biochem J; 1986 Dec; 240(3):879-83. PubMed ID: 3827876
[TBL] [Abstract][Full Text] [Related]
44. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
45. Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.
Boumah CE; Hogue DL; Cass CE
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):987-96. PubMed ID: 1472012
[TBL] [Abstract][Full Text] [Related]
46. 2'-deoxyadenosine induces apoptosis in rat chromaffin cells.
Wakade AR; Guo X; Palmer KC; Kulkarni JS; Przywara DA; Wakade TD
J Neurochem; 1996 Dec; 67(6):2273-81. PubMed ID: 8931458
[TBL] [Abstract][Full Text] [Related]
47. The kinetics of dissociation of the inhibitor of nucleoside transport, nitrobenzylthioinosine, from the high-affinity binding sites of cultured hamster cells.
Koren R; Cass CE; Paterson AR
Biochem J; 1983 Nov; 216(2):299-308. PubMed ID: 6661198
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological characterization of rapidly accumulated adenosine by dissociated brain cells from adult rat.
Geiger JD; Johnston ME; Yago V
J Neurochem; 1988 Jul; 51(1):283-91. PubMed ID: 3379409
[TBL] [Abstract][Full Text] [Related]
49. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
50. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
Keil GJ; Delander GE
J Pharmacol Exp Ther; 1995 Sep; 274(3):1387-92. PubMed ID: 7562512
[TBL] [Abstract][Full Text] [Related]
51. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
Hammond JR
Mol Pharmacol; 1991 Jun; 39(6):771-9. PubMed ID: 2051991
[TBL] [Abstract][Full Text] [Related]
52. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
[TBL] [Abstract][Full Text] [Related]
53. Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.
Fang X; Parkinson FE; Mowles DA; Young JD; Cass CE
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):457-65. PubMed ID: 8713072
[TBL] [Abstract][Full Text] [Related]
54. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223
[TBL] [Abstract][Full Text] [Related]
55. Effects of nucleoside transport inhibitors and adenine/ribose on ATP concentration and adenosine production in cardiac myocytes.
Kalsi KK; Smolenski RT; Yacoub MH
Adv Exp Med Biol; 1998; 431():95-8. PubMed ID: 9598038
[No Abstract] [Full Text] [Related]
56. Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
Sinclair CJ; Powell AE; Xiong W; LaRivière CG; Baldwin SA; Cass CE; Young JD; Parkinson FE
Br J Pharmacol; 2001 Nov; 134(5):1037-44. PubMed ID: 11682452
[TBL] [Abstract][Full Text] [Related]
57. Adenosine production and release by adult rat cardiocytes.
Bukoski RD; Sparks HV
J Mol Cell Cardiol; 1986 Jun; 18(6):595-605. PubMed ID: 3016289
[TBL] [Abstract][Full Text] [Related]
58. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
Plagemann PG; Wohlhueter RM
Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
[TBL] [Abstract][Full Text] [Related]
59. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.
Parker MD; Hyde RJ; Yao SY; McRobert L; Cass CE; Young JD; McConkey GA; Baldwin SA
Biochem J; 2000 Jul; 349(Pt 1):67-75. PubMed ID: 10861212
[TBL] [Abstract][Full Text] [Related]
60. Sensitivity to inhibition by N-ethylmaleimide: a property of nitrobenzylthioinosine-sensitive equilibrative nucleoside transporter of murine myeloma cells.
Lee CW; Goh LB; Tu Y
Biochim Biophys Acta; 1995 Aug; 1268(2):200-8. PubMed ID: 7662709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
